Investigating the impact of landscape fire smoke on dialysis patients' health
REACH Center Research Project 2
This study is looking at how breathing in smoke from wildfires might affect people with end-stage kidney disease who are on dialysis, especially in terms of their health and survival, and it will also check if having air conditioning at home can help reduce some of these risks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10982794 on NIH RePORTER |
What this research studies
This research focuses on understanding how long-term exposure to fine particulate matter (PM2.5) from landscape fire smoke affects patients with end-stage renal disease (ESRD) who are on dialysis. It aims to explore the relationship between this exposure and mortality rates among these patients, particularly in the context of climate change. Additionally, the study will assess whether having residential air conditioning can mitigate some of the health risks associated with PM2.5 exposure. By analyzing data and engaging with the community, the research seeks to provide valuable insights into environmental health risks for dialysis patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with end-stage renal disease who are currently undergoing dialysis treatment.
Not a fit: Patients who are not on dialysis or do not have end-stage renal disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health guidelines and interventions for dialysis patients, potentially reducing mortality rates associated with environmental factors.
How similar studies have performed: Previous research has indicated that short-term exposure to PM2.5 increases mortality risk among dialysis patients, but this study aims to explore long-term effects, making it a novel investigation.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Applebaum, Katie M. — George Washington University
- Study coordinator: Applebaum, Katie M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.